Bladder Cancer Therapeutics and Diagnostics Market - Growth, Trends, and Forecast (2019 - 2024)

The Market is segmented by Cancer Type (Transitional Cell Bladder Cancer, Superficial Bladder Cancer, Invasive Bladder Cancer, Squamous Cell Bladder Cancer and Other Rare Types), Therapeutics, Diagnostics and Geography

Market Snapshot

Asia Pacific Electrophysiology Market_1
Study Period:

2016-2024

Base Year:

2018

Fastest Growing Market:

Asia Pacific

Largest Market:

North America

CAGR:

4.0%

Key Players:

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Market Overview

The bladder cancer therapeutics and diagnostics market will show rapid growth due to increasing awareness about bladder diseases and available therapies, increasing healthcare expenditure and innovations in drug development. There has been a rapid increase in the overall healthcare expenditure globally over the past few years. Therefore there are new medical technologies, treatments, and medicines available for these bladder cancer diseases that contribute majorly in the overall rise in the healthcare costs. The high drug prices, drug patent expiry, and cost of healthcare services account for two-thirds of the rise in healthcare spending. The expenditure on increased services, which includes costs of labor and productivity (in biopharmaceutical industries) is also one of the major factors driving the healthcare costs.

In addition, the growing research in the development of innovative bladder cancer therapies and the presence of pipeline therapeutics are further propelling the growth of the bladder cancer therapeutics market. Furthermore, the rise in awareness about bladder cancer and their available therapies, growing smoking and tobacco consumption are also motivating the market.

Scope of the Report

As per the scope of the report, bladder cancer is a tumor, which starts in the cells of the bladder. Bladder cancer is the rapid, uncontrolled growth of abnormal cells in the urinary bladder lining with epithelial cells. These cancerous cells may even spread through the lining into the muscular wall of the bladder. At present, a number of therapies have evolved to treat bladder cancers, which in turn build a high demand for the bladder cancer therapeutics market.

 

By Cancer Type
Transitional Cell Bladder Cancer
Superficial Bladder Cancer
Invasive Bladder Cancer
Squamous Cell Bladder Cancer
Other Rare Types
By Therapeutics
Chemotherapy
Immunotherapy
Radiation Therapy
Surgery
By Diagnostics
Cystoscopy
Biopsy
Urinalysis
Bladder Ultrasound
Other Diagnostics
Geography
North America
US
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Cystoscopy is Anticipated to be the Dominant Segment in Diagnostics during the Forecast Period

Cystoscopy is a procedure used to see the interiors of the bladder and urethra using a telescope. A cystoscope is a specialized endoscope that is inserted through the urethra into the bladder to allow direct visual inspection of the urothelium. Cystoscopy is thus cost-effective, though in combination with other tests, the cost varies. There are approximately 1.2 million flexible cystoscopy procedures conducted annually in the United States, and thus the introduction of Cysview is boosting the growth of the market, and is expected to record a higher growth rate, during the forecast period.

Asia Pacific Electrophysiology Market_2

To understand key trends, Download Sample Report

North America Region Holds the Largest Market Share of Bladder Therapeutics And Diagnostics Market

The ecosystem for research and development for drugs for cancer is well established in North America, particularly in the US. Additionally, the presence of a large number of biologics companies and biopharmaceutical companies is contributing to the large size and excellent growth of bladder cancer therapeutics and diagnostics market.

North America also has the best adoption rates of new diagnostic modalities that are introduced in commercial space. This trend is in contrast with other regions of the world where the most widely adopted technologies for cancer diagnostics are at least a decade old. Consequently, North America is a leader in terms of the market size in the global bladder therapeutics and diagnostics market.

3_Injectable Drug Delivery Devices Market

To understand geography trends, Download Sample Report

Competitive Landscape

The major companies active in the market are AstraZeneca, Bristol-Myers Squibb, Celgene, Eli Lilly, Epocrates, Genentech, GlaxoSmithKline, Roche, Merck & Co, Novartis, Pfizer and so on. The companies present in the market are found focusing on product innovations, expansions, finding new markets or innovating their core competency to expand their individual market share.

Major Players

  1. Astra Zeneca Plc.
  2. Bristol Myers Squibb
  3. Eli Lilly and Co.
  4. GlaxoSmithKline Plc.
  5. Celgene Corporation

* Complete list of players covered available in the table of contents below

Asia Pacific Electrophysiology Market_3

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Awareness About Bladder Diseases and Available Therapies

      2. 4.2.2 Increasing Healthcare Expenditure

      3. 4.2.3 Innovations in Drug Development

    3. 4.3 Market Restraints

      1. 4.3.1 Rise in the Number of Patent Expirations

      2. 4.3.2 Asymptomatic Nature of the Disease

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Cancer Type

      1. 5.1.1 Transitional Cell Bladder Cancer

      2. 5.1.2 Superficial Bladder Cancer

      3. 5.1.3 Invasive Bladder Cancer

      4. 5.1.4 Squamous Cell Bladder Cancer

      5. 5.1.5 Other Rare Types

    2. 5.2 By Therapeutics

      1. 5.2.1 Chemotherapy

      2. 5.2.2 Immunotherapy

      3. 5.2.3 Radiation Therapy

      4. 5.2.4 Surgery

    3. 5.3 By Diagnostics

      1. 5.3.1 Cystoscopy

      2. 5.3.2 Biopsy

      3. 5.3.3 Urinalysis

      4. 5.3.4 Bladder Ultrasound

      5. 5.3.5 Other Diagnostics

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 US

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 UK

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Astra Zeneca Plc.

      2. 6.1.2 Bristol Myers Squibb

      3. 6.1.3 Celgene Corporation

      4. 6.1.4 Eli Lilly and Co.

      5. 6.1.5 GlaxoSmithKline Plc.

      6. 6.1.6 F Hoffmann-La Roche AG

      7. 6.1.7 Novartis International AG

      8. 6.1.8 Pfizer Inc.

      9. 6.1.9 Sanofi S.A.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please Enter a Valid Message!


Complete your payment details below

Shipping & Billing Information

Payment Information